Welcome to Isotopia USA!
We are currently working on our new Isotopia USA corporate website to better serve our partners and customers.
In the meantime, you are welcome to learn more about Isotopia and our global operations, and you are invited to reach out to us with any questions infoUSA@isotopia-global.com
Isotopia USA
Lu-177 Production You Can Rely On — Manufactured and Supplied from the U.S.
Operating from our headquarters in Indianapolis, Indiana, Isotopia USA supports the advancement of radiopharmaceutical therapy through reliable, high-quality U.S.-based production of Lutetium-177 (Lu-177). Our GMP-certified facility produces n.c.a. Lu-177 at scale, with an annual capacity exceeding 200,000 doses—providing consistent supply and operational confidence for clinical and commercial partners.
Reliable U.S. Supply, Built Around Clinical Needs
Timely isotope availability is critical to patient care. By manufacturing and distributing Lu-177 within the United States, Isotopia USA helps reduce risks associated with cross-border shipping, customs delays, and time-sensitive transport challenges. Our streamlined logistics processes and real-time shipment visibility are designed to support predictable delivery schedules and dependable service for nuclear medicine teams.
Backed by more than a decade of global experience, Isotopia supports healthcare providers and pharmaceutical partners with clinically validated Lu-177 solutions produced to stringent quality requirements.
Advanced GMP Manufacturing Infrastructure
Our 30,000-square-foot U.S. facility is fully GMP compliant and purpose-built for radiopharmaceutical production. It includes advanced cleanrooms for aseptic manufacturing, dedicated quality control and microbiology laboratories, and controlled materials handling systems that safeguard product integrity throughout the entire production cycle. This integrated approach enables precision, purity, and consistency in every Lu-177 batch we supply.
Expanding Beyond Lu-177
As targeted radionuclide therapy continues to evolve, Isotopia USA is expanding its capabilities to include Terbium-161 and additional next-generation isotopes. We also offer finished drug product manufacturing for preclinical, clinical, and commercial programs—providing flexible solutions that support development pipelines from early research through market supply.
A Practical Partner for the Future of Nuclear Medicine
Whether you are planning clinical programs or scaling commercial supply, Isotopia USA offers a reliable U.S. platform for high-quality radiopharmaceutical manufacturing. Our focus on operational excellence, regulatory compliance, and dependable delivery helps clinical teams stay on schedule—so they can focus on patients, not logistics.